A study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions

Published:2014 Issue:1 Volume:46 Page:117
ISSN:0253-7613
Container-title:Indian Journal of Pharmacology
language:en
Short-container-title:Indian J Pharmacol

Author:

Munshi RenukaP,Belhekar MaheshN,Taur SantoshR

Publisher

Medknow

Subject

Pharmacology (medical),Pharmacology

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A two-stage ensemble learning based prediction and grading model for PD-1/PD-L1 inhibitor-related cardiac adverse events: A multicenter retrospective study;Computer Methods and Programs in Biomedicine;2024-10

2. Revolutionizing drug discovery: The impact of artificial intelligence on advancements in pharmacology and the pharmaceutical industry;Intelligent Pharmacy;2024-06

3. Inter-rater agreement between WHO- Uppsala Monitoring Centre system and Naranjo algorithm for causality assessment of adverse drug reactions;Journal of Pharmacological and Toxicological Methods;2024-05

4. Manic episode associated with baclofen use: A case report;Bipolar Disorders;2024-04-22

5. Analysis of Favipiravir Adverse Drug Reactions during COVID-19 Pandemic: A Retrospective Study Based on Iraqi Pharmacovigilance Center Database;Al Mustansiriyah Journal of Pharmaceutical Sciences;2024-04-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP